Latest Content

Noha Ekdawi, MD, FAAP, explains why pediatric myopia demands individualized, progression-based management.

The company announced phase 2 results of a dual-action lifitegrast/perfluorohexyloctane dry eye drop alongside positive phase 1b results for BL1332, a first-in-class TRPV1 antagonist for ocular surface pain.

Teacher-led vision screening identified about 3 in 4 children with refractive error and correctly cleared most unaffected students.

The FDA has expanded the indication to include improvement of meibomian gland function in adult patients with evaporative dry eye disease due to MGD, making it the first treatment with this indication.

This review summarizes major contact lens risks, solution-related adverse effects, higher-risk populations, and practical prevention strategies for optometric practice.

Perceived stress modestly predicted later dry eye symptoms in young adults, but significance depended on a prespecified 1-tailed test.

Carolyn Majcher, OD, FAAO, discussed the impact of the FDA's approval of the drug for wet AMD after nearly 2 decades of off-label use.

The Class II recall alerts consumers and physicians to possible temporary or reversible health effects, but serious harm is unlikely.

Recommending omega-3 fatty acids in the diet of a patient with DED could lead to improved tear osmolarity and tear breakup time and thus fewer dry eye symptoms.

Corrected presbyopes used larger fonts, held smartphones farther away, and read more slowly, suggesting 40-cm testing may miss device demands.

Katie W. Chu, OD, personalizes care towards her community by fostering proactive conversations with patients. She stopped by to discuss her recommendations for pediatric contact lens and LASIK consultation.

A maternal high-fat diet can negatively affect the retinal structure in mice.

Catch up on the top stories in optometry during the week of August 10-14.